What question did this study set out to answer?

To evaluate the effectiveness of hyperdiluted calcium hydroxylapatite-carboxymethylcellulose in treating forearm dermatoporosis.

April 15, 2026Open Access

Calcium Hydroxylapatite‐Carboxymethylcellulose as a Treatment for Forearm Dermatoporosis: A Prospective, Delayed‐Start, Contralateral Case Series

Key Points

To evaluate the effectiveness of hyperdiluted calcium hydroxylapatite-carboxymethylcellulose in treating forearm dermatoporosis.
Conducted a prospective, delayed-start, contralateral case series
Administered a single session of hyperdiluted CaHA-CMC
Assessed outcomes using clinical evaluations, histologic examinations, and ultrasonographic measurements.
Achieved rapid clinical improvement in dermatoporosis symptoms
Showed durable histologic enhancements
Confirmed ultrasonographic improvements in treated areas.

Abstract

A single session of hyperdiluted CaHA-CMC produced rapid and durable clinical, histologic, and ultrasonographic improvement in forearm dermatoporosis. Findings warrant further evaluation in larger controlled trials.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Ada Regina Trindade de Almeida

Maria Cortez de Sousa Marins Barbosa

Alexandre Michalany

Journals

Journal of Cosmetic Dermatology

Actions

Institutions

Hospital do Servidor Público Municipal

Merz (United States)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Calcium Hydroxylapatite‐Carboxymethylcellulose as a Treatment for Forearm Dermatoporosis: A Prospective, Delayed‐Start, Contralateral Case Series

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study